Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Qualitest Pharmaceuticals, a wholly owned subsidiary of Endo Pharmaceuticals, has received the US Food and Drug Administration's (FDA) approval for dexamethasone elixir, USP, 0.5mg/ 5ml and Orsythia Tablets (levonorgestrel and ethinyl estradiol tablets, USP, 0.1mg/0.02mg).
Subscribe to our email newsletter
Dexamethasone elixir, a corticosteroid, is indicated for the treatment for variety of conditions including endocrine disorders, rheumatic disorders, and collagen diseases.
Dexamethasone elixir works by decreasing or preventing tissues from responding to inflammation.
Orsythia Tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.